Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Mizuho Financial Group Inc. Sponosred ADR (Japan) (MFG) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance

Mizuho Financial Group Inc. Sponosred ADR (Japan)Trade
Roivant Sciences Ltd. Common SharesTrade

Price performance (Past 24H)

Key statistics

Mizuho Financial Group Inc. Sponosred ADR (Japan) vs Roivant Sciences Ltd. Common Shares — how do they compare? Mizuho Financial Group Inc. Sponosred ADR (Japan) trades at $10.41 (market cap $132.18B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B). The key difference: Mizuho Financial Group Inc. Sponosred ADR (Japan) is far larger — about 5.3× Roivant Sciences Ltd. Common Shares's market cap, and Mizuho Financial Group Inc. Sponosred ADR (Japan) pays a 1.7% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Mizuho Financial Group Inc. Sponosred ADR (Japan) for 0 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.

MFGROIV
Market Cap
$132.18B$25.09B
Volume
3,264,6625,738,571
Sector
FinancialsHealth
52-Week High
$11.45$41.81
52-Week Low
$6.09$16.04
Typical Hold Time
0 Days0 Days
Enterprise Value
$35.48T$21.36B
Dividend Yield
1.7%—

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MFG
100% Buy0% Sell
Avg holding period · 0 Days
ROIV
100% Buy0% Sell
Avg holding period · 0 Days

About Mizuho Financial Group Inc. Sponosred ADR (Japan)

Mizuho Financial Group is a Japanese financial services company offering banking, trust, securities, and asset management services. It serves retail, corporate, and institutional clients globally.

Read more on MFG →

About Roivant Sciences Ltd. Common Shares

Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.

Read more on ROIV →